SCHEMBL2373825

SCHEMBL2373825

Cc1ncc(Cl)c(C(=O)O)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 4/20 0.51
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 3/20 0.40
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.40
XBP1 P17861 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TLR9 Q9NR96 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NAPRT Q6XQN6 1/20 0.38
SORT1 Q99523 1/20 0.38
KMO O15229 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30345120 1.00 MEN1 (0.61) MEN1KMT2ATDP1ALDH1A1ATM
SCHEMBL19125533 0.79 TP53 (0.42) MEN1KMT2AALDH1A1SMN1; SMN2TP53
SCHEMBL26287659 0.79 NPSR1 (0.47) MEN1KMT2ATDP1ALDH1A1ATM
SCHEMBL12858036 0.79 MEN1 (0.38) MEN1KMT2ATDP1ALDH1A1SMN1; SMN2
SCHEMBL5078316 0.79 MEN1 (0.59) MEN1KMT2ATDP1ALDH1A1ATM
SCHEMBL28012847 0.78 MEN1 (0.37) MEN1KMT2ATDP1ALDH1A1SMN1; SMN2
SCHEMBL13313461 0.78 HPGD (0.46) MEN1KMT2ATDP1ALDH1A1MAPT
SCHEMBL9423230 0.77 ALDH1A1 (0.67) MEN1KMT2ATDP1ALDH1A1MAPK1
SCHEMBL630361 0.76 KMT2A (0.36) MEN1KMT2ATDP1ALDH1A1SMN1; SMN2
SCHEMBL27730537 0.76 KMT2A (0.36) MEN1KMT2ATDP1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3431096-B1 GLUCOCORTICOID COMBINED WITH POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 FOR TREATING RESPIRATORY DISEASE XIE YANHUI (CN) 2024-12-18 EP claimed
EP-3840769-B1 CYCLOSPORINE COMPOSITIONS AND METHODS OF USE BACAINN BIOTHERAPEUTICS LTD (KY) 2024-07-24 EP claimed
EP-2643002-B1 PHARMACEUTICAL FORMULATIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION BAUSCH HEALTH IRELAND LTD (IE) 2023-01-04 EP claimed
EP-4149929-B1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AG (DE) 2026-01-28 EP disclosed
US-12520844-B2 Triazine and pyrimidine (thio)amides as fungicidal compounds BAYER AKTIENGESELLSCHAFT (DE) 2026-01-13 US disclosed
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed
US-20230180756-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2023-06-15 US disclosed
EP-4149929-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS Bayer Aktiengesellschaft (DE) 2023-03-22 EP disclosed
CN-115605462-A Triazine and pyrimidine (thio) amides as fungicidal compounds 拜耳公司(DE) 2023-01-13 CN disclosed
WO-2021228734-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2021-11-18 WO disclosed
EP-3204383-B1 SPIRODIAMINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS HOFFMANN LA ROCHE (CH) 2020-11-18 EP disclosed
CN-102791714-A N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as PDE10A inhibitors HOFFMANN LA ROCHE 2012-11-21 CN disclosed
US-20110237564-A1 IMIDAZOPYRIMIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2011-09-29 US disclosed
WO-2011117264-A1 N-(IMIDAZOPYRIMIDIN-7-YL)-HETEROARYLAMIDE DERIVATIVES AND THEIR USE AS PDE10A INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2011-09-29 WO disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed
EP-0497851-B1 SULPHONATED HETEROCYCLIC CARBOXAMIDES AS HERBICIDES, GROWTH REGULATORS OR FUNGICIDES HOECHST SCHERING AGREVO GMBH (DE) 1995-01-04 EP disclosed
US-5324710-A Sulfonated heterocyclic carboxamides and their use as herbicides, and growth regulators HOECHST AKTIENGESELLSCHAFT (DE) 1994-06-28 US disclosed
EP-0497851-A1 SULPHONATED HETEROCYCLIC CARBOXAMIDES AS HERBICIDES, GROWTH REGULATORS OR FUNGICIDES. HOECHST AG (DE) 1992-08-12 EP disclosed
WO-1991006541-A1 SULPHONATED HETEROCYCLIC CARBOXAMIDES AS HERBICIDES, GROWTH REGULATORS OR FUNGICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180756-A1 TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS TPMT, TYMP, TPI1 MEN1 4691/4885KMT2A 1688/4885TDP1 447/4885
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CDK1, CDKN1A, CDKL1 MEN1 750/4885KMT2A 1487/4885TDP1 609/4885
US-20110237564-A1 IMIDAZOPYRIMIDINE DERIVATIVES PDE5A, PDE3B, PDE3A MEN1 3260/4885KMT2A 2872/4885TDP1 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.